A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir
Clinical trial NCT04034368 · UNKNOWN
Trial details
- NCT number
- NCT04034368
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2021-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.